1a,7b-Dihydro-1H-cyclopropa[c]chromen-2-one
Common Name: |
1a,7b-Dihydro-1H-cyclopropa[c]chromen-2-one |
IUPAC Name: |
1a,7b-dihydro-1H-cyclopropa[c]chromen-2-one |
Molecular Formula: |
C11H18O |
SMILES: |
C1C2C1C(=O)OC3=CC=CC=C23 |
Inchi: |
1S/C10H8O2/c11-10-8-5-7(8)6-3-1-2-4-9(6)12-10/h1-4,7-8H,5H2 |
Inchi Key: |
BSNSPNHWEMGXBT-UHFFFAOYSA-N |
Cas No: |
5617-64-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
166.26 |
Mass (g/mol) |
160.052 |
Molar Refractivity |
52.34 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
4 |
Rings |
3 |
TPSA |
17.07 |
Hetero Atoms |
2 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
245.00 to 246.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.028 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.73 |
LogP |
1.709 |
iLOGP |
2.58 |
XLOGP3 |
3.37 |
WLOGP |
2.96 |
MLOGP |
2.49 |
ESOL Log S |
-2.73 |
ESOL Solubility (mg/ml) |
0.31 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.41 |
Ali Solubility (mg/ml) |
0.07 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.47 |
Silicos-IT Solubility (mg/ml) |
0.56 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.92 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.824 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
3.296 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |